Literature DB >> 1908584

Effects of ritanserin on aversive classical conditioning in humans.

R Hensman1, F S Guimarães, M Wang, J F Deakin.   

Abstract

According to one formulation of the behavioural functions of 5HT, aversive conditioned stimuli mediate their behavioural and emotional effects through activation of 5HT projections from dorsal raphe nucleus to receptors of the 5HT2 family in amygdala and elsewhere. To test this theory in humans, groups of ten normal volunteers received placebo, the 5HT2 lc antagonist ritanserin (10 mg PO) and no pill. Ritanserin had no effect on skin conductance level, variability (spontaneous fluctuations) or habituation to a sequence of ten neutral tones. After a conditioning trial in which tone 11 was followed by an aversive white noise, skin conductance responses to a further ten tones were enhanced. This effect was abolished by ritanserin. The results indicate a selective involvement of 5HT2/lc receptors in modulating aversively conditioned skin conductance responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908584     DOI: 10.1007/bf02244182

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Characterization of a psychophysiological model of classical fear conditioning in healthy volunteers: influence of gender, instruction, personality and placebo.

Authors:  F S Guimarães; J Hellewell; R Hensman; M Wang; J F Deakin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Conditioned emotional responding under diazepam: a psychophysiological study of state dependent learning.

Authors:  H H Jensen; B Hutchings; J C Poulsen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  5HT2 receptors, depression and anxiety.

Authors:  J F Deakin
Journal:  Pharmacol Biochem Behav       Date:  1988-04       Impact factor: 3.533

Review 4.  5-HT and anxiety.

Authors:  S D Iversen
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

5.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

6.  Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.

Authors:  J A Den Boer; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

Authors:  R J Kahn; D M McNair; R S Lipman; L Covi; K Rickels; R Downing; S Fisher; L M Frankenthaler
Journal:  Arch Gen Psychiatry       Date:  1986-01

8.  Evaluation of a psychophysiological model of classical fear conditioning in anxious patients.

Authors:  K R Ashcroft; F S Guimarães; M Wang; J F Deakin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Dimensions of neuroses seen in primary-care settings.

Authors:  D P Goldberg; K Bridges; P Duncan-Jones; D Grayson
Journal:  Psychol Med       Date:  1987-05       Impact factor: 7.723

10.  Neurotic illness and its response to anxiolytic and antidepressant treatment.

Authors:  E C Johnstone; D G Owens; C D Frith; K McPherson; C Dowie; G Riley; A Gold
Journal:  Psychol Med       Date:  1980-05       Impact factor: 7.723

View more
  15 in total

Review 1.  Serotonin 2A receptors are a stress response system: implications for post-traumatic stress disorder.

Authors:  Kevin Sean Murnane
Journal:  Behav Pharmacol       Date:  2019-04       Impact factor: 2.293

2.  Impaired recognition of fear facial expressions in 5-HTTLPR S-polymorphism carriers following tryptophan depletion.

Authors:  Abigail A Marsh; Elizabeth C Finger; Beata Buzas; Niveen Soliman; Rebecca A Richell; Meena Vythilingham; Daniel S Pine; David Goldman; R J R Blair
Journal:  Psychopharmacology (Berl)       Date:  2006-09-30       Impact factor: 4.530

3.  Tryptophan depletion decreases the recognition of fear in female volunteers.

Authors:  C J Harmer; R D Rogers; E Tunbridge; P J Cowen; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  2003-04-04       Impact factor: 4.530

4.  Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.

Authors:  Antonio Pedro de Mello Cruz; Gilson Pinheiro; Sérgio Henrique Alves; Graziela Ferreira; Marília Mendes; Letícia Faria; Carlos Eduardo Macedo; Vitor Motta; J Landeira-Fernandez
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 5.  5HT drugs in animal models of anxiety.

Authors:  S L Handley; J W McBlane
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Role of the serotonin 5-HT(2A) receptor in learning.

Authors:  John A Harvey
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

7.  Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin.

Authors:  J M da Roza Davis; A L Sharpley; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 8.  The neural underpinnings of cognitive flexibility and their disruption in psychotic illness.

Authors:  James A Waltz
Journal:  Neuroscience       Date:  2016-06-07       Impact factor: 3.590

9.  Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.

Authors:  Nesha S Burghardt; David E A Bush; Bruce S McEwen; Joseph E LeDoux
Journal:  Biol Psychiatry       Date:  2007-05-23       Impact factor: 13.382

10.  Effects of acute selective 5-HT1, 5-HT2, 5-HT3 receptor and alpha 2 adrenoceptor blockade on naloxone-induced antinociception.

Authors:  M J Walker; C X Poulos; A D Le
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.